| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/2005 | US6887882 Comprises (5bR-(5b-a,6b,12b-a))-5b,6,7,12b,13,14-hexahydro-13 -methyl(1,3)benzodioxolo(5,6c)-1,3-dioxolo(4,5-i)phenanthrid in-6-ol; for use as antiarrhythmic drugs; potassium channel modulators |
| 05/03/2005 | US6887881 For use as antiarrhythmic drug |
| 05/03/2005 | US6887879 Pharmaceutical combination of antiviral agents |
| 05/03/2005 | US6887878 KMST isoeugenol derivatives and pharmaceutical activity |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887876 Benzamidine derivatives |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887873 Nitrogen heteroaromatic ring connected with the same or another aromatic ring through a triazine distribution agent; anticancer agents |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887869 Mikanolide derivatives, their preparation and therapeutic uses |
| 05/03/2005 | US6887868 Therapeutic 5-HT ligand compounds |
| 05/03/2005 | US6887866 Short-acting sedative hypnotic agents for anesthesia and sedation |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887864 Anticancer agents, a benzoylamino-azepan-3-yl-isonicotinamide compounds |
| 05/03/2005 | US6887860 Administering carbocyclic alcohols, for prophylaxis of skin disorders such as psoriasis; vitamins |
| 05/03/2005 | US6887859 Topical compositions containing fluid-absorbent solids and adhesive fluids |
| 05/03/2005 | US6887858 Method of treating dry eye disease with purinergic receptor agonists |
| 05/03/2005 | US6887855 Crystal structure; for treatment of myelodysplastic syndromes |
| 05/03/2005 | US6887853 Administering an inhibitor selected from the group consisting of macbecin, herbimycin, galdanamycin and derivatives and analoge thereof; and pharaceutically acceptable inert carrier vehicle for therapy |
| 05/03/2005 | US6887845 Polypeptoid pulmonary surfactants |
| 05/03/2005 | US6887843 Chlamydia protein, gene sequence and uses thereof |
| 05/03/2005 | US6887712 By lowering levels of circulating low/very low density lipoproteins (LDL/VLDL); solid phase synthesis; sandwich immunoreactive assay; agarose electrophoresis; detecting in vivo complex formation |
| 05/03/2005 | US6887676 For diagnosis/therapy/prevention of Creutzfeldt-Jacob disease |
| 05/03/2005 | US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering |
| 05/03/2005 | US6887502 Compositions comprising fat soluble substances in a glassy carbohydrate matrix |
| 05/03/2005 | US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators |
| 05/03/2005 | US6887499 Mixture of jasmone compound, antioxidant and carnitine |
| 05/03/2005 | US6887497 Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function |
| 05/03/2005 | US6887487 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 05/03/2005 | US6887474 Compositions and methods for producing vascular occlusion |
| 05/03/2005 | US6887469 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 05/03/2005 | US6887460 Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines |
| 05/03/2005 | US6887459 Administering inhalant with particulate carrier or diluent for treatment of chronic obstructive pulmonary disease |
| 05/03/2005 | US6887458 Bead comprising mixture of polyvinyl alcohol and platinum (and titania) isotoped by neutron radiation; anticarcinogenic and antitumor agents |
| 05/03/2005 | US6887260 Method and apparatus for acne treatment |
| 05/03/2005 | CA2486473A1 Vaginal care composition |
| 05/03/2005 | CA2437412C Delayed release microtablet of b-phenylpropiophenone derivatives |
| 05/03/2005 | CA2390636C Stabilized formulations comprising amlodipine maleate |
| 05/03/2005 | CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 05/03/2005 | CA2339594C Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof |
| 05/03/2005 | CA2325045C Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 05/03/2005 | CA2320388C Novel dihydroxyhexanoic acid derivatives |
| 05/03/2005 | CA2309558C Substituted oximes as neurokinin antagonists |
| 05/03/2005 | CA2297486C 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
| 05/03/2005 | CA2269054C Method of treatment of heart disease caused by chlamydia pneumoniae |
| 05/03/2005 | CA2236677C 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents |
| 05/03/2005 | CA2208704C 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
| 05/03/2005 | CA2202531C Lyophilizate of lipid complex of water insoluble camptothecins |
| 05/03/2005 | CA2201477C New pyrimidone derivatives with antifungal activity |
| 05/03/2005 | CA2193994C Process for synthesis of substituted sulphoxides |
| 05/03/2005 | CA2184598C Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 05/03/2005 | CA2158999C Crystalline benzathine salt of cefonicid and its preparation |
| 05/03/2005 | CA2157234C Stereoselective process for producing dihydro-2-3-benzodiazepine derivatives |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 05/03/2005 | CA2114114C Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 05/03/2005 | CA2103189C Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes |
| 05/03/2005 | CA2096001C Compositions of gastric acid-resistant microspheres containing salts of bile acid |
| 05/03/2005 | CA2089767C Pyridinyl thiadiazolyl- and oxadiazolyl derivatives |
| 04/30/2005 | CA2553542A1 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad |
| 04/28/2005 | WO2005051363A1 Coated conditioners for use in foods and pharmaceuticals |
| 04/28/2005 | WO2005038465A2 Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors |
| 04/28/2005 | WO2005038042A2 Systems and methods for assessing neuronal degeneration |
| 04/28/2005 | WO2005038037A2 Methods for preparing phospholipids containing omega-3 and omega-6 moieties |
| 04/28/2005 | WO2005038013A1 Artisense oligonucleotides optimized for kidney targeting |
| 04/28/2005 | WO2005038009A2 Production of tacrolimus (fk-506) using new streptomyces species |
| 04/28/2005 | WO2005037995A2 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy |
| 04/28/2005 | WO2005037949A2 Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine |
| 04/28/2005 | WO2005037928A2 Compounds for dual photodiagnosis and therapy |
| 04/28/2005 | WO2005037895A1 Pectin films prepared from gamma irradiated pectin |
| 04/28/2005 | WO2005037868A2 Methods of treating nfat-related disorders |
| 04/28/2005 | WO2005037851A1 Crystalline forms of 3-beta-amino 17-methylene androstane-6-alpha 7-beta-diol hydrochloride |
| 04/28/2005 | WO2005037848A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 04/28/2005 | WO2005037845A1 Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors |
| 04/28/2005 | WO2005037843A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | WO2005037842A1 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 04/28/2005 | WO2005037841A1 Concentricolide and its derivatives, the preparation of the same, and pharmaceutical compositions containing the same and the use |
| 04/28/2005 | WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 04/28/2005 | WO2005037837A1 SUBSTITUTED 2-AMINO-[1,2,4]TRIAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 04/28/2005 | WO2005037836A2 Imidazo ‘1, 5 - a ! pyrazine tyrosine kinase inhibitors |
| 04/28/2005 | WO2005037833A1 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity |
| 04/28/2005 | WO2005037832A2 Azabicycyclic compounds for relieving pain and treating central nervous system disorders |
| 04/28/2005 | WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2005 | WO2005037829A1 1,3-benzoxazolyl derivatives as kinase-inhibitors |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037825A2 Protein kinase inhibitors |
| 04/28/2005 | WO2005037824A2 Method for the production of amino crotonyl compounds |
| 04/28/2005 | WO2005037816A1 Use of 8-prenylnaringenin for hormone replacement therapy |
| 04/28/2005 | WO2005037814A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 04/28/2005 | WO2005037812A1 Furan derivatives as ep4 receptor antagonists |
| 04/28/2005 | WO2005037799A1 Compounds, compositions, and methods |
| 04/28/2005 | WO2005037797A1 Substituted pyrazole urea compounds for the treatment of inflammation |
| 04/28/2005 | WO2005037790A1 Preparation of 3-azabicyclo [3.1.0] hexane derivatives |
| 04/28/2005 | WO2005037784A2 Crystalline form of gamma-aminobutyric acid analog |
| 04/28/2005 | WO2005037780A2 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
| 04/28/2005 | WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037776A1 Novel molecule for inducing differentiation of dendritic cells |